Impact of Low Immunoglobulin G Levels on Disease Outcomes in Patients with Inflammatory Bowel Diseases

[1] Foersch S(2013)Innate and adaptive immunity in inflammatory bowel diseases Dig Dis 31 317-320

[2] Waldner MJ(2011)Innate and adaptive immunity in inflammatory bowel disease World J Gastroenterol 17 3178-3183

[3] Neurath MF(2010)Increased response and remission rates in short-duration Crohn’s disease with subcutaneous certolizumab pegol: an analysis of PRECiSE 2 randomized maintenance trial data Am J Gastroenterol 105 1574-1582

[4] Siegmund B(2006)Human anti-tumor necrosis factor monoclonal antibody (adalimumab) in Crohn’s disease: the CLASSIC-I trial Gastroenterology 130 323-333

[5] Zeitz M(2007)Adalimumab induction therapy for Crohn disease previously treated with infliximab: a randomized trial Ann Intern Med 146 829-838

[6] Schreiber S(1976)Serum immunoglobulin levels in ulcerative colitis: an investigation Nurs Times. 72 137-139

[7] Colombel JF(1974)The immune competence of patients with inflammatory bowel disease Gut 15 213-219

[8] Bloomfield R(1969)Serum immunoglobulins and organ-specific, cellular hypersensitivity in ulcerative colitis and Crohn’s disease Acta Med Scand. 186 87-91

[9] Hanauer SB(1971)Serum concentration of 19 serum proteins in Crohn’s disease and ulcerative colitis Gut 12 297-302

[10] Sandborn WJ(1977)Immunological studies in inflammatory bowel disease Ciba Found Symp 46 283-304

[1] Foersch S(2013)Innate and adaptive immunity in inflammatory bowel diseases Dig Dis 31 317-320

[2] Waldner MJ(2011)Innate and adaptive immunity in inflammatory bowel disease World J Gastroenterol 17 3178-3183

[3] Neurath MF(2010)Increased response and remission rates in short-duration Crohn’s disease with subcutaneous certolizumab pegol: an analysis of PRECiSE 2 randomized maintenance trial data Am J Gastroenterol 105 1574-1582

[4] Siegmund B(2006)Human anti-tumor necrosis factor monoclonal antibody (adalimumab) in Crohn’s disease: the CLASSIC-I trial Gastroenterology 130 323-333

[5] Zeitz M(2007)Adalimumab induction therapy for Crohn disease previously treated with infliximab: a randomized trial Ann Intern Med 146 829-838

[6] Schreiber S(1976)Serum immunoglobulin levels in ulcerative colitis: an investigation Nurs Times. 72 137-139

[7] Colombel JF(1974)The immune competence of patients with inflammatory bowel disease Gut 15 213-219

[8] Bloomfield R(1969)Serum immunoglobulins and organ-specific, cellular hypersensitivity in ulcerative colitis and Crohn’s disease Acta Med Scand. 186 87-91

[9] Hanauer SB(1971)Serum concentration of 19 serum proteins in Crohn’s disease and ulcerative colitis Gut 12 297-302

[10] Sandborn WJ(1977)Immunological studies in inflammatory bowel disease Ciba Found Symp 46 283-304